Loading...
Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts
Dunnett-Kane, V Burkitt-Wright, E Blackhall, Fiona H Malliri, Angeliki Evans, G Lindsay, Colin R
Dunnett-Kane, V
Burkitt-Wright, E
Blackhall, Fiona H
Malliri, Angeliki
Evans, G
Lindsay, Colin R
Citations
Altmetric:
Abstract
Description
Date
2020
Publisher
Collections
Keywords
Type
Article
Citation
Ettl J, Tolaney S, Wardley A, Zambelli S, Hilton JF, Ricci F, et al. Monarcher: A Randomized Phase 2 Study of Abemaciclib Plus Trastuzumab with or without Fulvestrant Versus Trastuzumab Plus Standard-of-Care Chemotherapy in Women with HR+, HER2+Advanced Breast Cancer. Oncology Research and Treatment. 2020;43:16-